ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The prognostic role of an optimal machine learning model based on clinical available indicators in HCC patients

Lou, Xiaoying; Ma, Shaohui; Ma, Mingyuan; Wu, Yue; Xuan, Chengmei; Sun, Yan; Liang, Yue; Wang, Zongdan; Gao, Hongjun*中国医学科学院; 中国医学科学院北京协和医院
Frontiers in Medicine2024-7-17DOI: 10.3389/fmed.2024.1431578
1被引5阅读
引用收藏
分享

摘要

Although methods in diagnosis and therapy of hepatocellular carcinoma (HCC) have made significant progress in the past decades, the overall survival (OS) of liver cancer is still disappointing. Machine learning models have several advantages over traditional cox models in prognostic prediction. This study aimed at designing an optimal panel and constructing an optimal machine learning model in predicting prognosis for HCC. A total of 941 HCC patients with completed survival data and preoperative clinical chemistry and immunology indicators from two medical centers were included. The OCC panel was designed by univariate and multivariate cox regression analysis. Subsequently, cox model and machine-learning models were established and assessed for predicting OS and PFS in discovery cohort and internal validation cohort. The best OCC model was validated in the external validation cohort and analyzed in different subgroups. In discovery, internal and external validation cohort, C-indexes of our optimal OCC model were 0.871 (95% CI, 0.863-0.878), 0.692 (95% CI, 0.667-0.717) and 0.648 (95% CI, 0.630-0.667), respectively; the 2-year AUCs of OCC model were 0.939 (95% CI, 0.920-0.959), 0.738 (95% CI, 0.667-0.809) and 0.725 (95% CI, 0.643-0.808), respectively. For subgroup analysis of HCC patients with HBV, aged less than 65, cirrhosis or resection as first therapy, C-indexes of our optimal OCC model were 0.772 (95% CI, 0.752-0.792), 0.769 (95% CI, 0.750-0.789), 0.855 (95% CI, 0.846-0.864) and 0.760 (95% CI, 0.741-0.778), respectively. In general, the optimal OCC model based on RSF algorithm shows prognostic guidance value in HCC patients undergoing individualized treatment.

学科与关键词

关键词
hepatocellular carcinoma (HCC)overall survival (OS)OS-related clinical characteristic (OCC) panelprogression-free survival (PFS)random survival forests (RSF)
相关
加载中…
  • Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning
    Liu, Wendao; Wei, Ran; Chen, Junwei; Li, Yangyang; Pang, Huajin; Zhang, Wentao; An, Chao*; Li, Chengzhi*European Radiology, 2024.
  • Machine learning algorithms based on proteomic data mining accurately predicting the recurrence of hepatitis B-related hepatocellular carcinoma
    Feng, Gong; He, Na; Xia, Harry Hua-Xiang; Mi, Man; Wang, Ke; Byrne, Christopher D.; Targher, Giovanni; Yuan, Hai-Yang; Zhang, Xin-Lei; Zheng, Ming-Hua*; Ye, Feng*Journal of Gastroenterology and Hepatology, 2022, 37(11): 2145-2153.被引 4
  • Short-term prognosis for hepatocellular carcinoma patients with lung metastasis: A retrospective cohort study based on the SEER database
    Chen, Shicheng; Li, Xiaowen; Liang, Yichao; Lu, Xinyu; Huang, Yingyi; Zhu, Jiajia; Li, Jun*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2022, 101(45): e31399.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Medicine
发表日期
2024-07-17
卷期
第 11 卷
页码
1431578
DOI
10.3389/fmed.2024.1431578
成果收录
SCIE
资助标注
CAMS Innovation Fund for Medical Sciences [2022-I2M-C, T-B-080]; Science and Technology Department Basic Research Project of Shanxi [202303021211225]

作者

  • L

    Lou, Xiaoying (第一作者)

    chinese acad med sci · peking union med coll

  • M

    Ma, Shaohui

    chinese acad med sci · peking union med coll

查看全部 9 位作者收起作者
  • M

    Ma, Mingyuan

  • W

    Wu, Yue

    chinese acad med sci · peking union med coll

  • X

    Xuan, Chengmei

    chinese acad med sci · peking union med coll

  • S

    Sun, Yan

    chinese acad med sci · shanxi med univ · shanxi prov canc hosp

  • L

    Liang, Yue

    chinese acad med sci · shanxi med univ · shanxi prov canc hosp

  • W

    Wang, Zongdan

    chinese acad med sci · peking union med coll

  • G

    Gao, Hongjun (通讯)

    chinese acad med sci · peking union med coll · shanxi med univ · shanxi prov canc hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417